Negocios · 5/5/19981 min de lectura
Guidance for Industry on National Uniformity for Nonprescription DrugsIngredient Listing for OTC Drugs; Availability; Clarification
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) is clarifying an administrative error relating to a notice that appeared in the Federal Register of April 9, 1998 (63 FR 17429). The notice announced the availability of a guidance for industry entitled ``National Uniformity for Nonprescription Drugs--Ingredient Listing for OTC Drugs.'' The agency displayed the incorrect draft of the guidance. This document clarifies that error.